Leonie Jochheim

Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experience

Tiago B. R. Castro, Leonie Jochheim, Melanie Bathon et al. · Therapeutic Advances in Medical Oncology · 2022 · 79 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Ipilimumab and nivolumab in advanced hepatocellular carcinoma after failure of prior immune checkpoint inhibitor-based combination therapies: a multicenter retrospective study

Daniel Roessler, Osman Öcal, Alexander Philipp et al. · Journal of Cancer Research and Clinical Oncology · 2022 · 40 citations · Full text

Life Sciences, Oncology, Pharmacotherapy +17

Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience

Friedrich Sinner, Matthias Pinter, Bernhard Scheiner et al. · Cancers · 2022 · 24 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Current use of percutaneous image-guided tumor ablation for the therapy of liver tumors: lessons learned from the registry of the German Society for Interventional Radiology and Minimally Invasive Therapy (DeGIR) 2018–2022

Sebastian Zensen, Arno Bücker, Mathias Meetschen et al. · European Radiology · 2023 · 17 citations · Full text

Medicine, Oncology, Surgery +14

Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: Multicenter real-world study with focus on bleeding and thromboembolic events

Najib Ben Khaled, Marie Møller, Leonie Jochheim et al. · JHEP Reports · 2024 · 16 citations · Full text

Medicine, Oncology, Pharmacology +13